Form 4 for LLY Lilly (Eli)
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-01 · accession 0001860253-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-02-01 | LLY | Rau Diogo | EVP, CIDO | M - OptEx | $0.00 | +3,752 | 23.5K | +19% | $0 |
| D | 2026-02-03 | 2026-02-01 | LLY | Rau Diogo | EVP, CIDO | F - Tax | $1,037.15 | -1,674 | 21.8K | -7% | -$1.74M |
| D | 2026-02-03 | 2026-02-01 | LLY | Rau Diogo | EVP, CIDO | M - OptEx | $0.00 | -3,752 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-01 | M | A | 3,752 | $0.00 | 23,470.91 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-01 | F | D | 1,673.54 | $1,037.15 | 21,797.37 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-02-01 | M | D | 3,752 | $0.00 | 0 | D | — · 2026-02-01 to 2026-02-01 | 3,752 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |